سعر ليف-جاما 2.5جم فيال حقن وريدي 2022

Liv-Gamma 2.5 g (SK Chemicals, Korea; Faripharma, Egypt): human normal immunoglobulin G for intravenous infusion, one vial; used for primary immunodeficiency and immunomodulation in immune disorders.

• Replacement therapy in primary immunodeficiency with impaired antibody production and in secondary immunodeficiency with severe/recurrent infections and specific antibody failure or serum IgG < 4 g/L.Ilac Prospektusu (hosting the Turkish approved SmPC, KÜB)
• Immunomodulation: immune thrombocytopenia at high bleeding risk or before surgery, Guillain-Barré syndrome, Kawasaki disease, multifocal motor neuropathy, chronic inflammatory demyelinating polyneuropathy (acute), and myasthenia gravis with bulbar involvement.Ilac Prospektusu (hosting the Turkish approved SmPC, KÜB)

• Very common: headache and myalgia. Common: decreased appetite, dizziness, oropharyngeal pain, nausea, urticaria, pruritus, acneiform dermatitis, fever, fatigue, feeling hot, decreased neutrophil count, increased C-reactive protein, weight gain.International label, equivalent formulation · Ilac Prospektusu (hosting the Turkish approved SmPC, KÜB)

• Hypersensitivity to the active substance or any excipient.International label, equivalent formulation · Ilac Prospektusu (hosting the Turkish approved SmPC, KÜB)
• Selective IgA deficiency with antibodies against IgA: IgA-containing products may cause anaphylaxis.International label, equivalent formulation · Ilac Prospektusu (hosting the Turkish approved SmPC, KÜB)

• Thromboembolism (myocardial infarction, stroke, pulmonary embolism, deep vein thrombosis) has been associated with IVIG; use caution and the minimum rate and dose in patients with thrombotic risk factors (advanced age, hypertension, diabetes, vascular disease or thrombosis history, thrombophilia, prolonged immobilisation, severe hypovolaemia, hyperviscosity).International label, equivalent formulation · Ilac Prospektusu (hosting the Turkish approved SmPC, KÜB)
• The SN formulation contains maltose (100 mg/mL), which can interfere with some blood glucose measurements and give falsely high readings, risking inappropriate insulin dosing or missed hypoglycaemia.International label, equivalent formulation · Ilac Prospektusu (hosting the Turkish approved SmPC, KÜB)
• Aseptic meningitis syndrome may occur within hours to 2 days, mostly with high doses (2 g/kg); haemolytic anaemia and transfusion-related acute lung injury (TRALI) have been reported; true hypersensitivity/anaphylaxis is rare but possible.International label, equivalent formulation · Ilac Prospektusu (hosting the Turkish approved SmPC, KÜB)

• No clinical data on exposure in pregnancy for LIV-GAMMA SN; IVIG crosses the placenta increasingly in the third trimester. Because parvovirus B19 transmission cannot be ruled out, use in pregnancy only if benefits outweigh risks.International label, equivalent formulation · Ilac Prospektusu (hosting the Turkish approved SmPC, KÜB)
• Excreted in breast milk; no negative effects on the breastfed infant are expected and it may help transfer protective antibodies.International label, equivalent formulation · Ilac Prospektusu (hosting the Turkish approved SmPC, KÜB)

• Human normal immunoglobulin G: Provides a broad spectrum of opsonising and neutralising IgG antibodies against infectious agents; immunomodulatory mechanisms in autoimmune indications are not fully elucidated.